GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,530
Funds Holding Change
+78
Funds Holding Growth
+2%
Value
$1.05T
Holding in Top 10
727
Top 10 Change
+121
Top 10 Growth
+20%
Value Growth
+6%
New
255
Increased
1,976
Reduced
1,996
Closed
133
Capital Inflow
$31.3B
Capital Outflow
$27.8B
Net Capital Flow
+$3.56B
Capital Flow Change
+$9.9B
Calls
$14.5B
Puts
$15B
Net Calls
-$474M
Put/Call Ratio
1.03